MetLife Investment Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $636K | Hold |
|
|||||
|
2023
Q4 | $691K | Hold |
|
|||||
|
2023
Q3 | $334K | Hold |
|
|||||
|
2023
Q2 | $472K | Buy |
|
|||||
|
2023
Q1 | $335K | Hold |
|
|||||
|
2022
Q4 | $437K | Buy |
|
|||||
|
2022
Q3 | $309K | Hold |
|
|||||
|
2022
Q2 | $196K | Hold |
|
|||||
|
2022
Q1 | $384K | Buy |
|
|||||
|
2021
Q4 | $503K | Hold |
|
|||||
|
2021
Q3 | $384K | Hold |
|
|||||
|
2021
Q2 | $317K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $131K | Buy |
|